QT-interval under substitution therapy with methadone;Das QT-intervall während der substitutionsbehandlung heroinabhängiger

Suchtmedizin in Forschung und Praxis

Volumn 7, Issue 2, 2005, Pages 161-164

  Backmund, Markus ^a   Henkel, Claudia ^a   Jordan, Frank ^a   Habsch, Jochen ^a   Meyer, Kirsten ^a   Kääb, Stefan ^b  

^a Klinikum Schwabing   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Drug addiction; Drug interaction; Methadone; QT interval; Tachycardia; Torsades de pointes

Indexed keywords

METHADONE; OPIATE;

ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG DEPENDENCE; DRUG SUBSTITUTION; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOKALEMIA; MALE; PRESCRIPTION; QT INTERVAL; QT PROLONGATION; TORSADE DES POINTES;

EID: 22044457058     PISSN: 14375567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Arzneimittelkommission der deutschen Aerzteschaft (2002): Auftreten von Kammertachykardien (Torsade de pointes) nach hoch dosierter Gabe von Methadon. Dt Aerztebl 99, B2831
2. Backmund M (1999): Substitutionsbehandlung. In: Backmund M, Hrsg.: Suchttherapie, ecomed Verlag, Landsberg/Lech, Kapitel IX: 1-6
3. Backmund M, Meyer K, Zwehl W, Nagengast O, Eichenlaub D (2001a): Myocardial infarction associated with methadone and/or dihydrocodeine. Eur Addict Res 7, 37-39
4. Backmund M, Meyer K, Eichenlaub D, Schuetz CG (2001b): Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Drug Alcohol Depend 64, 173-180
5. Backmund M, Schuetz CG, Meyer K, Eichenlaub D, Soyka M (2003): Alcohol Consumption in Heroin Users, Methadone-Substituted and Codeine-Substituted Patients - Frequency and Correlates of Use. Eur Addict Res 9, 45-50
6. Basdekis R, Krausz M (2002): Psychiatrische Komorbidität als Risikofaktor bei Drogennotfällen. In: Kraus L, Püschel K, Hrsg.: Prävention von drogenbedingten Not- und todesfällen. Lambertus-Verlag, Freiburg, S. 99-123
7. Cracowski JL, Mallaret M, Vanazetto G (1990): Myocardial infarction associated with buprenorphine. Ann Intern Med 130, 537
8. Crouch MA, Limon L, Cassano AT (2003): Critical relevance and management of drug-related QT-interval prolongation. Pharmacotherapy 23, 881-908
9. Darke S, Ross J, Hall W (1996): Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction 91, 405-411
10. Darke S, Hall W (2003): Heroin overdose: research and evidence-based intervention. J Urban Health 80, 189-200
11. Deamer RL, Wilson DR, Clark DS, Prichard JG (2001): Torsade de pointes associated with high dose levomethadyl acetate (ORLAAM). J Addict Dis 20, 7-14
12. Dole VP, Nyswander M (1965): Medical treatment for diacetylmorhine (heroin) addiction. JAMA 193, 646-650
13. Frishman WH, Del Vecchio A, Sanal S, Ismail A (2003): Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Dis 5, 253-271
14. Guedon-Moreau L, Ducrocq D, Due MF, Quieureux Y, L'Hote C, Deligne J, Caron J (2003): Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescritptions in 1999. Eur J Clin Pharmacol 59 (8-9), 689-695
15. Glauser FL, Downie RL, Smith WR (1977): Electrocardiographic abnormalities in acute heroin overdose. Bull Narc 29,85-89
16. Jurnal (1984): Analgetika-Schmerzbekampfung. In: Forth W, Henschler D, Rummel W, Hrsg.: Pharmakologie und Toxikologie. Bl Wissenschaftsverlag, Zürich, S. 470-481
17. Karir V (2002): Bradycardia associated with intravenous methadone administered for sedation in a patient with acute respirator distress syndrome. Pharmacotherapy 22, 1196-1199
18. Krausz M (2003): Substitutionsbehandlung. In: Krausz M, Haasen C, Naber D, Hrsg.: Pharmakotherapie der Sucht. Karger Verlag, Freiburg-Basel, S. 105-158
19. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS (2002): Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 137, 501-504
20. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS (2003): Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 23, 802-805
21. Szatajzel J, Karpuz H, Rutishauser W (1994): Heroin abuse and myocardial infarction. Int J Cardiol 47, 180-182
22. Walker PW, Klein D, Kasza L (2003): High dose methadone and ventricular arryhtmias: a report of three cases. Pain 103, 321-324
23. Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S (2003): Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 82, 282-290